Arguello-Tomas, M, Lynton-Pons, E, Albiol, N, Lopez-Ferrer, A, Sierra, J, Moga, E, Moreno, C. Clinical and immunologic characteristics of nonhematologic autoimmune disorders in chronic lymphocytic leukemia. CANCER. 2025; 131(24)DOI:10.1002/cncr.70216. PMID:41378669. IF:5.100(Q1/3D).

Monje, A, Escolà-Vergé, L, Rivera, A, Herrera, S, Plaza, A, Duch-Llorach, P, Pomar, V, Roch, N, Rouras, L, Lopez-Contreras, J, Ramos, JR. Targeting Overtreatment of Asymptomatic Bacteriuria in the Emergency Department: Results from a Quasi-Experimental Clinical Pharmacist-Led Program Based on Education and Audit. Antibiotics-Basel. 2025; 14(12)DOI:10.3390/antibiotics14121261. PMID:41463763. IF:4.600(Q1/2D).

Ulugut, H, Younes, K, Montembeault, M, Bertoux, M, Irish, M, Kumfor, F, Fumagalli, GG, Samanci, B, Illán-Gala, I, Thompson, JC, Santillo, AF, Englund, E, Waldö, ML, Riedl, L, van den Stock, J, Vandenbulcke, M, Vandenberghe, R, Laforce, R, Ducharme, S, Pressman, PS, Caramelli, P, de Souza, LC, Takada, LT, Gurvit, H, Diehl-Schmid, J, Galimberti, D, Pasquier, F, Weintraub, S, Miller, BL, Sturm, VE, Whitwell, JL, Boeve, B, Rohrer, JD, Piguet, O, Gorno-Tempini, ML, Josephs, KA, Snowden, J, Rowe, JB, Warren, JD, Rankin, KP, Pijnenburg, YAL. Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group. Communications Medicine. 2025; 5(1)DOI:10.1038/s43856-025-01252-4. PMID:41387629. IF:(Q/D).

Julve, J, Rodriguez-Calvo, R, Perret, B, Martinez, LO, Mauricio, D. Targeting Atherosclerosis: Cholesterol-Lowering Therapies with a New Immunometabolic Dress for an Old Disease. Journal of Clinical Medicine. 2025; 14(24)DOI:10.3390/jcm14248777. PMID:41464678. IF:2.900(Q1/2D).

Camacho-Meño, L, Labandeira, CM, Bravo, SB, Torres, MV, Bejr-Kasem, H, Molina-Crespo, A, Atienza, M, Lanciego, JL, Cantero, JL, Kulisevsky, J, Labandeira-Garcia, JL, Rodriguez-Perez, AI. Brain-derived extracellular vesicle proteomics reveals neuroprotection induced by the ARB candesartan in Parkinson's disease patients. npj Parkinsons Disease. 2025; 12(1)DOI:10.1038/s41531-025-01230-6. PMID:41366251. IF:8.200(Q1/1D).

Diaz-Moreno, U, Brothwell, SLC, Darling, A, Baide-Mairena, H, Lemonde, H, Turon-Viñas, E, Korenev, S, Ibañez, S, Beesley, C, Gissen, P, Parida, A, Santra, S, Wassmer, E, Batzios, S. From Neonatal Encephalopathy to Adult Survival: Revisiting the Natural History of D-Bifunctional Protein Deficiency in a Multicentre International Case Series. JOURNAL OF INHERITED METABOLIC DISEASE. 2025; 49(1)DOI:10.1002/jimd.70118. PMID:41367148. IF:3.800(Q2/3D).

Rubio-Guerra, S, Sala, I, Sánchez-Saudinos, MB, Videla, L, Bejanin, A, Estanga, A, Ecay-Torres, M, de Luis, CL, Rami, L, Tort-Merino, A, Castellví, M, Pozueta, A, García-Martínez, M, Gomez-Andrés, D, Lage, C, Lopez-García, S, Sánchez-Juan, P, Balasa, M, Llado, A, Altuna, M, Tainta, M, Arranz, J, Zhu, NL, Alcolea, D, Lleo, A, Fortea, J, Rodríguez, ER, Sánchez-Valle, R, Martínez-Lage, P, Illán-Gala, I. Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapies. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2025; 17(4)DOI:10.1002/dad2.70223. PMID:41383878. IF:(Q/D).

Liberale, L, Vilahur, G, Carbone, F. Multidisciplinary meetings to provide the best cardiovascular care: the European Society for Clinical Investigation. EUROPEAN HEART JOURNAL. 2025; 46(46)DOI:10.1093/eurheartj/ehaf739. PMID:41078253. IF:35.600(Q1/1D).